NDC 43063-744
Bupropion Hydrochloridesr 150 mg tablet, extended release
On the label: PD-Rx Pharmaceuticals, Inc.. It's repackaged: PD-Rx Pharmaceuticals, Inc. rebottles it from Cipla USA., Inc.'s NDC 69097-878.
Where the pills inside were made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| InvaGen Pharmaceuticals, Inc | Hauppauge, NY, United States | Makes it and tests it | No problems foundOct 25, 2023 · 18 inspections |
| InvaGen Pharmaceuticals, Inc | Central Islip, NY, United States | Tests it and packages it | Problems found, fixed voluntarilyJul 17, 2026 · 4 inspections |
Repackaging site
- PD-Rx Pharmaceuticals Inc., Oklahoma City, OK, United States · repackages it
Recalls
- Mar 15, 2018 · Class III · InvaGen Pharmaceuticals, Inc.
Failed Dissolution Specifications; during stability testing
Lots: Lot# I1606579 and Lot# I1606580 Exp: 05/2018; Lot# I1612114 and Lot# I1612115 Exp: 11/2018 - Mar 15, 2018 · Class III · InvaGen Pharmaceuticals, Inc.
Failed Dissolution Specifications; during stability testing
Lots: a) Lot I1606609 and Lot I1606610 Exp. Date 05/2018; Lot I1610639 Exp. Date 09/2018 b) Lot #I1606610 Exp Date 05/2018; Lot I1607847 and Lot I1607845 Exp Date 06/2018; Lot I1610639 Exp Date 09/2018
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Bupropion: every company that makes it
- Form
- tablet, extended release, oral
- Strength
- 150 mg
- Approval
- ANDA ANDA206674
- On the market since
- Jul 25, 2016
- Package NDCs
43063-744-30- Official label
- DailyMed (National Library of Medicine), updated Oct 16, 2025
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?